ArticleArthritis and rheumatism2013

A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Elise E Drouin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.